DE69029069D1 - Verwendung von Xanthinderivaten gegen Magengeschwüre - Google Patents

Verwendung von Xanthinderivaten gegen Magengeschwüre

Info

Publication number
DE69029069D1
DE69029069D1 DE69029069T DE69029069T DE69029069D1 DE 69029069 D1 DE69029069 D1 DE 69029069D1 DE 69029069 T DE69029069 T DE 69029069T DE 69029069 T DE69029069 T DE 69029069T DE 69029069 D1 DE69029069 D1 DE 69029069D1
Authority
DE
Germany
Prior art keywords
xanthine derivatives
stomach ulcers
derivatives against
against stomach
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69029069T
Other languages
English (en)
Other versions
DE69029069T2 (de
Inventor
Toshizo Tanaka
Shoryo Hayashi
Yuko Morioka
Ulrich Dr Gebert
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis KK
Original Assignee
Hoechst Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan Ltd filed Critical Hoechst Japan Ltd
Publication of DE69029069D1 publication Critical patent/DE69029069D1/de
Application granted granted Critical
Publication of DE69029069T2 publication Critical patent/DE69029069T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DE69029069T 1989-08-16 1990-08-11 Verwendung von Xanthinderivaten gegen Magengeschwüre Expired - Fee Related DE69029069T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21018789 1989-08-16

Publications (2)

Publication Number Publication Date
DE69029069D1 true DE69029069D1 (de) 1996-12-12
DE69029069T2 DE69029069T2 (de) 1997-04-10

Family

ID=16585226

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69029069T Expired - Fee Related DE69029069T2 (de) 1989-08-16 1990-08-11 Verwendung von Xanthinderivaten gegen Magengeschwüre

Country Status (18)

Country Link
US (1) US5109003A (de)
EP (1) EP0413278B1 (de)
JP (1) JP2977242B2 (de)
KR (1) KR910004620A (de)
AT (1) ATE144900T1 (de)
AU (1) AU624987B2 (de)
CA (1) CA2023310A1 (de)
DD (1) DD298051A5 (de)
DE (1) DE69029069T2 (de)
DK (1) DK0413278T3 (de)
ES (1) ES2094132T3 (de)
GR (1) GR3021569T3 (de)
HU (1) HU207518B (de)
IE (1) IE902954A1 (de)
IL (1) IL95377A (de)
NZ (1) NZ234896A (de)
PT (1) PT95007A (de)
ZA (1) ZA906446B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0570831A2 (de) * 1992-05-20 1993-11-24 Hoechst Aktiengesellschaft Verwendung von Xanthinderivaten zur Behandlung von Nervenschädigungen nach Unterbrechung der Blutzirkulation
US5354756A (en) * 1993-01-12 1994-10-11 Cell Therapeutics, Inc. Olefin-substituted long chain xanthine compounds
DE4411660A1 (de) * 1994-04-05 1995-10-12 Hoechst Ag Verwendung von Xanthinderivaten zur Reduktion der pathologischen Hyperreagibilität eosinophiler Granulozyten, neue Xanthinverbindungen und Verfahren zu deren Herstellung
US7122207B2 (en) * 1998-05-22 2006-10-17 Bristol-Myers Squibb Company High drug load acid labile pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3525801A1 (de) * 1985-07-19 1987-01-22 Hoechst Ag Tertiaere hydroxyalkylxanthine, verfahren zu ihrer herstellung, die sie enthaltenden arzneimittel und ihre verwendung
JPS63225317A (ja) * 1986-10-06 1988-09-20 Hoechst Japan Kk 抗消化性潰瘍剤
IL100533A (en) * 1986-12-31 1994-05-30 Hoechst Roussel Pharma Pharmaceutical preparations containing a history of xanthine for VIH treatment and disease states
JP2661666B2 (ja) * 1988-02-19 1997-10-08 ヘキスト薬品工業株式会社 抗消化性潰瘍剤

Also Published As

Publication number Publication date
GR3021569T3 (en) 1997-02-28
JPH03163019A (ja) 1991-07-15
JP2977242B2 (ja) 1999-11-15
HU905000D0 (en) 1991-01-28
EP0413278B1 (de) 1996-11-06
EP0413278A2 (de) 1991-02-20
AU624987B2 (en) 1992-06-25
HU207518B (en) 1993-04-28
ATE144900T1 (de) 1996-11-15
ZA906446B (en) 1991-05-29
KR910004620A (ko) 1991-03-29
IL95377A (en) 1994-08-26
EP0413278A3 (en) 1992-05-06
HUT54688A (en) 1991-03-28
NZ234896A (en) 1993-10-26
CA2023310A1 (en) 1991-02-17
DE69029069T2 (de) 1997-04-10
IL95377A0 (en) 1991-06-30
DK0413278T3 (da) 1997-04-07
PT95007A (pt) 1991-04-18
AU6101890A (en) 1991-02-21
DD298051A5 (de) 1992-02-06
IE902954A1 (en) 1991-02-27
ES2094132T3 (es) 1997-01-16
US5109003A (en) 1992-04-28

Similar Documents

Publication Publication Date Title
NO892058D0 (no) Fremgangsnaate for fremstilling av terapeutisk aktive benzamider.
ATE143014T1 (de) Benzimidazol-derivate und therapeutische, diese enthaltende mittel gegen ulcer
IE860222L (en) Imidazole derivatives.
DK0508740T3 (da) Thiazolidindionderivater, deres fremstilling og anvendelse.
ES2046229T3 (es) Composicion antiulcerosa.
ES2038710T3 (es) Un procedimiento de preparacion de un derivado de benzoxazina y su utilizacion.
DE69029069D1 (de) Verwendung von Xanthinderivaten gegen Magengeschwüre
ATE63541T1 (de) N-phenylethylaminoalkyl-benzamide als antiarrhythmische mittel.
IL89324A0 (en) Therapeutic agents for the treatment of peptic ulcer disease containing xanthine derivatives
ATE137759T1 (de) S'-adenosyl-methionin-decarboxylase-inhibitoren
ATE75399T1 (de) Therapeutikum zur behandlung von magengeschwueren.
NO893039D0 (no) Bruk av imidazopyrazol-derivater som analgesiske og antiinflammatoriske midler.
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee